Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING

Exactech Shoulder Post Market Clinical Follow-up Study

NCT05603728 · View on ClinicalTrials.gov ↗

Study Summary

The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder arthroplasty over time. This study will follow subjects long-term for a minimum of 10-years, without an early-term restriction on the amount of time they will be followed.

Study Locations (20)

Florida

  • UF Health Orthopaedics and Sports Medicine Institute — Gainesville
  • Mayo Clinic — Jacksonville
  • Palm Beach Orthopaedic Institute — Palm Beach Gardens
  • Florida Atlantis Orthopedics — Palm Beach Gardens
  • Orthopaedic Medical Group of Tampa Bay — Tampa

California

  • South County Orthopedic Specialists — Laguna Woods
  • Stanford Health Care — Redwood City
  • Alpine Orthopaedic Medical Group — Stockton

Colorado

  • Western Orthopaedics — Denver
  • Orthopaedic and Spine Center of the Rockies — Fort Collins

Illinois

  • OrthoIllinois — Rockford
  • Barrington Orthpedic Specialists — Schaumburg

New York

  • Hospital for Joint Diseases - NYU Langone Health — New York
  • Lenox Health Greenwich Village — New York

North Carolina

  • Southeastern Sports Medicine and Orthopedics — Asheville
  • Duke Department of Orthopedic Surgery — Durham

Georgia

  • Orthopedic and Sports Medicine — Augusta

Michigan

  • Henry Ford Health — Detroit

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2007-07-19
Est. Completion 2031-12-31

Sponsor

Exactech

34 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05603728

The ClinicalTrials.gov registry entry for NCT05603728 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exactech, which has 34 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 9 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05603728 reports 20 study locations spanning 10 distinct geographic areas — top geographies include Florida, California, Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05603728 about?

NCT05603728 is a clinical study titled "Exactech Shoulder Post Market Clinical Follow-up Study". The objective of this study is to collect and evaluate long-term clinical and radiographic outcomes data in order to better understand the safety and performance of the shoulder arthroplasty over time. This study will follow subjects long-term for a minimum of 10-years, without an early-term restric...

What is the current status of trial NCT05603728?

This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2007-07-19. Estimated completion is 2031-12-31.

What conditions does trial NCT05603728 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Infections, Rotator Cuff Tears, Ankylosing Spondylitis, Fracture. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

Who is sponsoring clinical trial NCT05603728?

This trial is sponsored by Exactech, which has 34 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05603728 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial